US OptionsDetailed Quotes
NVO241220C123000
- 0.01
- -0.44-97.78%
15min DelayClose Dec 20 16:00 ET
0.21High0.01Low
0.01Open0.45Pre Close17 Volume592 Open Interest123.00Strike Price37.00Turnover0.00%IV44.72%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma8500.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Novo-Nordisk A/S Stock Discussion
Sign in to post a comment
$Novo-Nordisk A/S (NVO.US)$ Waoooo so cheapp now
1
$Novo-Nordisk A/S (NVO.US)$
no idea whats up w/ nvo for entry but nvox is a new leaveraged ticker. it just started recently so hadn't had a chance to go up yet before tanking. this is the complete history of ticker.
$Defiance Daily Target 2X Long NVO ETF (NVOX.US)$
no idea whats up w/ nvo for entry but nvox is a new leaveraged ticker. it just started recently so hadn't had a chance to go up yet before tanking. this is the complete history of ticker.
$Defiance Daily Target 2X Long NVO ETF (NVOX.US)$
6
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Devastating Crash of $Novo-Nordisk A/S (NVO.US)$ and Strong Rebound of $NVIDIA (NVDA.US)$ on Black Friday.
I made a difficult but crucial decision on Friday to sell off losing positions at pre-market which were moving downtrend so badly like $Novo-Nordisk A/S (NVO.US)$ , $D.R. Horton (DHI.US)$ , $Huntington Ingalls Industries (HII.US)$ , $MarketAxess (MKTX.US)$ . Especially obesity drug giant NVO which collapsed 25% at pre-market after disappointing trial results o...
I made a difficult but crucial decision on Friday to sell off losing positions at pre-market which were moving downtrend so badly like $Novo-Nordisk A/S (NVO.US)$ , $D.R. Horton (DHI.US)$ , $Huntington Ingalls Industries (HII.US)$ , $MarketAxess (MKTX.US)$ . Especially obesity drug giant NVO which collapsed 25% at pre-market after disappointing trial results o...
loading...
6
I sold out of $Novo-Nordisk A/S (NVO.US)$ early on Thursday and bought into $Micron Technology (MU.US)$ at just below $85, perfectly dodging Friday’s drop on Novo and getting into Micron at fire sale prices.
I’d like to think that it was the result of some 9-dimensional formula with repeatable outputs…but in actuality, it was just financial Ultra Instinct (with even less consistency and internal logic than Goku’s powers)…
I got out of Novo for reasons ...
I’d like to think that it was the result of some 9-dimensional formula with repeatable outputs…but in actuality, it was just financial Ultra Instinct (with even less consistency and internal logic than Goku’s powers)…
I got out of Novo for reasons ...
3
1
$Novo-Nordisk A/S (NVO.US)$ i bought dip. honedt opinions
1
By the end of the day, the market had regained some ground lost when the FOMC released less promising inflation predictions for 2025 after cutting rates on Wednesday.
At the closing bell 4 pm ET, the S&P 500 climbed 1.28%, the Dow Jones Industrial Average climbed 1.52%, and the Nasdaq Composite Index climbed 1.21%.
MACRO
In macro, Personal Consumption Expenditure numbers came in lower than expected, 2.4% vs 2.5%, but trending higher...
At the closing bell 4 pm ET, the S&P 500 climbed 1.28%, the Dow Jones Industrial Average climbed 1.52%, and the Nasdaq Composite Index climbed 1.21%.
MACRO
In macro, Personal Consumption Expenditure numbers came in lower than expected, 2.4% vs 2.5%, but trending higher...
45
7
3
$Novo-Nordisk A/S (NVO.US)$ this dip is on the average as the dips that happened over the past 5 years. buy to climb back to 110.
1
1
$Novo-Nordisk A/S (NVO.US)$ BUY UP SO CHEAP
2
Happy Friday, traders. It's December 20th, and the market fell at the opening bell, but prices recovered after snow began falling on Wall Street. Since the FOMC Wednesday meeting, markets have trended lower. PCE inflation numbers came in lower than expected- growing at 2.4% and core prices at 2.8%.
$Novo-Nordisk A/S (NVO.US)$ Shares dropped 20% after a trial of the CagriSema obesity drug, which showed that patients lost 22.7% o...
$Novo-Nordisk A/S (NVO.US)$ Shares dropped 20% after a trial of the CagriSema obesity drug, which showed that patients lost 22.7% o...
20
7
6
Pick 1 : $Novo-Nordisk A/S (NVO.US)$
Pick 2: $ASML Holding (ASML.US)$
Pick 3: $Nike (NKE.US)$
Pick 4: $Adobe (ADBE.US)$
Pick 5: $PepsiCo (PEP.US)$
Pick 2: $ASML Holding (ASML.US)$
Pick 3: $Nike (NKE.US)$
Pick 4: $Adobe (ADBE.US)$
Pick 5: $PepsiCo (PEP.US)$
6
2
No comment yet
Money Thrill : Indeed, time to follow and buy? the results or better statistics of research are not really relevant and are open to interpretation. I research it and write an article about it later. Price could go up too much![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
People only read it halfway ...